1. Kerr DJ, Haller DG, van de Velde CJH, Baumann M (2016) Oxford textbook of oncology. Oxford University Press
2. Duffy A, Le J, Sausville E, Emadi A (2015) Autophagy modulation: a target for cancer treatment development. Cancer Chemother Pharmacol 75:439–447. https://doi.org/10.1007/s00280-014-2637-z
3. Levy JMM, Thorburn A (2011) Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 131:130–141. https://doi.org/10.1016/j.pharmthera.2011.03.009
4. Nehme G, Gordon N (2020) Autophagy in Osteosarcoma. In: Current Advances in the Science of Osteosarcoma. Springer, pp 167–175
5. Camuzard O, Santucci-Darmanin S, Carle GF, Pierrefite-Carle V (2019) Role of autophagy in osteosarcoma. J bone Oncol 16:100235. https://doi.org/10.1016/j.jbo.2019.100235
6. Li X, Xu H, Liu Y, et al (2013) Autophagy modulation as a target for anticancer drug discovery. Acta Pharmacol Sin 34:612–624. https://doi.org/10.1038/aps.2013.23
7. Yang ZJ, Chee CE, Huang S, Sinicrope F (2011) Autophagy modulation for cancer therapy. Cancer Biol Ther 11:169–176. https://doi.org/10.4161/cbt.11.2.14663
8. Mizushima N, Levine B (2010) Autophagy in mammalian development and differentiation. Nat Cell Biol 12:823–830. https://doi.org/10.1038/ncb0910-823
9. Yu L, Chen Y, Tooze SA (2018) Autophagy pathway: cellular and molecular mechanisms. Autophagy 14:207–215. https://doi.org/10.1080/15548627.2017.1378838
10. Doherty J, Baehrecke EH (2018) Life, death and autophagy. Nat Cell Biol 20:1110–1117. https://doi.org/10.1038/s41556-018-0201-5
11. Madrigal-Matute J, Cuervo AM (2016) Regulation of Liver Metabolism by Autophagy. Gastroenterology 150:328–339. https://doi.org/https://doi.org/10.1053/j.gastro.2015.09.042
12. Menon MB, Dhamija S (2018) Beclin 1 phosphorylation–at the center of autophagy regulation. Front Cell Dev Biol 6:137
13. Vega-Rubín-de-Celis S (2020) The Role of Beclin 1-Dependent Autophagy in Cancer. Biology (Basel) 9:4. https://doi.org/10.3390/biology9010004
14. Singh SS, Vats S, Chia AY-Q, et al (2018) Dual role of autophagy in hallmarks of cancer. Oncogene 37:1142–1158. https://doi.org/10.1038/s41388-017-0046-6
15. Rosenfeldt MT, Ryan KM (2011) The multiple roles of autophagy in cancer. Carcinogenesis 32:955–963. https://doi.org/10.1093/carcin/bgr031
16. Kung C-P, Budina A, Balaburski G, et al (2011) Autophagy in tumor suppression and cancer therapy. Crit Rev Eukaryot Gene Expr 21:71–100. https://doi.org/10.1615/CritRevEukarGeneExpr.v21.i1.50
17. Chen H-Y, White E (2011) Role of autophagy in cancer prevention. Cancer Prev Res 4:973–983. https://doi.org/10.1158/1940-6207.CAPR-10-0387
18. White E, Mehnert JM, Chan CS (2015) Autophagy, Metabolism, and Cancer. Clin Cancer Res 21:5037–5046. https://doi.org/10.1158/1078-0432.CCR-15-0490
19. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev cancer 12:401–410. https://doi.org/10.1038/nrc3262
20. Vera E, Bernardes de Jesus B, Foronda M, et al (2012) The Rate of Increase of Short Telomeres Predicts Longevity in Mammals. Cell Rep 2:732–737. https://doi.org/10.1016/j.celrep.2012.08.023
21. Louzon M, Coeurdassier M, Gimbert F, et al (2019) Telomere dynamic in humans and animals: Review and perspectives in environmental toxicology. Environ Int 131:105025. https://doi.org/10.1016/j.envint.2019.105025
22. Zhang Y, Cai L, Wei R-X, et al (2011) Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines. Oncol Lett 2:1327–1332. https://doi.org/10.3892/ol.2011.403
23. Stögbauer L, Stummer W, Senner V, Brokinkel B (2019) Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas–A systematic review. Neurosurg Rev 43:1–8. https://doi.org/10.1007/s10143-019-01087-3
24. Günes C, Rudolph KL (2013) The role of telomeres in stem cells and cancer. Cell 152:390–393. https://doi.org/10.1016/j.cell.2013.01.010
25. Reddel RR (2003) Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 194:155–162
26. Fernandes SG, Dsouza R, Pandya G, et al (2020) Role of telomeres and Telomeric proteins in human malignancies and their therapeutic potential. Cancers (Basel) 12:1901. https://doi.org/10.3390/cancers12071901
27. Martinez P, Blasco MA (2010) Role of shelterin in cancer and aging. Aging Cell 9:653–666. https://doi.org/10.1111/j.1474-9726.2010.00596.x
28. Sobinoff AP, Pickett HA (2017) Alternative Lengthening of Telomeres: DNA Repair Pathways Converge. Trends Genet 33:921–932. https://doi.org/https://doi.org/10.1016/j.tig.2017.09.003
29. Cesare AJ, Reddel RR (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11:319. https://doi.org/10.1038/nrg2763
30. Sfeir A, De Lange T (2012) Removal of shelterin reveals the telomere end-protection problem. Science (80- ) 336:593–597. https://doi.org/10.1126/science.1218498
31. Loayza D, De Lange T (2003) POT1 as a terminal transducer of TRF1 telomere length control. Nature 423:1013–1018
32. Artandi SE, Attardi LD (2005) Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 331:881–890. https://doi.org/10.1016/j.bbrc.2005.03.211
33. Patel TNV, Vasan R, Gupta D, et al (2015) Shelterin proteins and cancer. Asian Pacific J Cancer Prev 16:3085–3090. https://doi.org/10.7314/APJCP.2015.16.8.3085
34. Linder B, Kögel D (2019) Autophagy in cancer cell death. Biology (Basel) 8:82. https://doi.org/10.3390/biology8040082
35. Su Z, Yang Z, Xu Y, et al (2015) Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 14:48. https://doi.org/10.1186/s12943-015-0321-5
36. Towers CG, Wodetzki D, Thorburn A (2020) Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations Autophagy and cancer. J Cell Biol 219:1–15. https://doi.org/10.1083/jcb.201909033
37. Taji F, Kouchesfahani HM, Sheikholeslami F, et al (2017) Autophagy induction reduces telomerase activity in HeLa cells. Mech Ageing Dev 163:40–45. https://doi.org/10.1016/j.mad.2016.12.011
38. Zhang T, Shen S, Qu J, Ghaemmaghami S (2016) Global Analysis of Cellular Protein Flux Quantifies the Selectivity of Basal Autophagy. Cell Rep 14:2426–2439. https://doi.org/https://doi.org/10.1016/j.celrep.2016.02.040
39. Rao S, Tortola L, Perlot T, et al (2014) A dual role for autophagy in a murine model of lung cancer. Nat Commun 5:1–15. https://doi.org/10.1038/ncomms4056
40. Lee YJ, Jang BK (2015) The role of autophagy in hepatocellular carcinoma. Int J Mol Sci 16:26629–26643. https://doi.org/10.3390/ijms161125984
41. Leal-Esteban LC, Fajas L (2020) Cell cycle regulators in cancer cell metabolism. Biochim Biophys Acta - Mol Basis Dis 1866:165715. https://doi.org/10.1016/j.bbadis.2020.165715
42. Ma X-H, Piao S, Wang D, et al (2011) Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin cancer Res 17:3478–3489. https://doi.org/10.1158/1078-0432.CCR-10-2372
43. Slavin SA, Leonard A, Grose V, et al (2018) Autophagy inhibitor 3-methyladenine protects against endothelial cell barrier dysfunction in acute lung injury. Am J Physiol Cell Mol Physiol 314:L388–L396. https://doi.org/10.1152/ajplung.00555.2016
44. Bharath LP, Agrawal M, McCambridge G, et al (2020) Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation. Cell Metab 32:44-55.e6. https://doi.org/https://doi.org/10.1016/j.cmet.2020.04.015
45. Maejima Y, Isobe M, Sadoshima J (2016) Regulation of autophagy by Beclin 1 in the heart. J Mol Cell Cardiol 95:19–25. https://doi.org/https://doi.org/10.1016/j.yjmcc.2015.10.032
46. Zhang Y, Qi H, Taylor R, et al (2007) The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy 3:337–346. https://doi.org/10.4161/auto.4127
47. Kamat PK, Kalani A, Kyles P, et al (2014) Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease. Cell Biochem Biophys 70:707–719. https://doi.org/10.1007/s12013-014-0006-5
48. Benhamou Y, Picco V, Raybaud H, et al (2016) Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma. Oncotarget 7:44236. https://doi.org/10.18632/oncotarget.10005
49. Bryan TM, Marušić L, Bacchetti S, et al (1997) The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 6:921–926. https://doi.org/10.1093/hmg/6.6.921
50. Muntoni A, Reddel RR (2005) The first molecular details of ALT in human tumor cells. Hum Mol Genet 14:R191–R196. https://doi.org/10.1093/hmg/ddi266
51. Celli GB, de Lange T (2005) DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 7:712–718. https://doi.org/10.1038/ncb1275
52. Denchi EL, De Lange T (2007) Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448:1068–1071. https://doi.org/10.1038/nature06065
53. Kumar R, Khan R, Gupta N, et al (2018) Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma. Leuk Lymphoma 59:1677–1689. https://doi.org/10.1080/10428194.2017.1387915
54. Dall’Armi C, Devereaux KA, Di Paolo G (2013) The role of lipids in the control of autophagy. Curr Biol 23:R33–R45. https://doi.org/10.1016/j.cub.2012.10.041
55. Hernandez-Diaz S, Soukup S-F (2020) The role of lipids in autophagy and its implication in neurodegeneration. Cell Stress 4:167. https://doi.org/10.15698/cst2020.07.225